Results 281 to 290 of about 3,301,468 (320)

Infection of dendritic cells by enterobacteriaceae

Medical Microbiology and Immunology, 2000
Dendritic cells (DC) are potent antigen-presenting cells that play a crucial role in initiation and modulation of specific immune responses. Various pathogens like viruses or bacteria are able to persist inside DC. In this study we investigated the ability of the Gram-negative bacteria Salmonella typhimurium and Escherichia coli to infect DC.
Andreas Simm, Hans-Iko Huppertz, A Bubert, Michael Schoppet   +3 more
openaire   +3 more sources

Oral enterobacteriaceae in patients with HIV infection

Journal of Oral Pathology & Medicine, 1990
160 oral swabs of 149 HIV‐infected patients and 168 swabs of 166 controls were cultured to detect a possible colonization of the oral cavity with yeasts and Enterobacteriaceae, In 5.0% of the HIV‐infected patients and in 4.8% of the controls different species of Enterobacteriaceae were found. Yeasts were always associated with Enterobacteriaceae in the
Peter A. Reichart, Franz J. Fehrenbach, A. Schmidt-Westhausen   +2 more
openaire   +3 more sources

A serologic response in human infection with Enterobacteriaceae

The American Journal of the Medical Sciences, 1977
Sera from patients infected with Escherichia coli, Proteus, Klebsiella, and Serratia were studied for precipitins to ultrasonic extracts of these organisms in gel-diffusion plates. Sera from 66 per cent of these patients contained precipitins when initially tested. Twenty-four per cent of sera tested in the first week after onset of infection contained
White A, James W. Smith, Rissing Jp, Crowder Jc   +3 more
openaire   +3 more sources

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections

Current Opinion in Infectious Diseases, 2018
Purpose of review In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections. CRE have historically been susceptible to polymyxins, tigecycline or aminoglycosides (mostly gentamicin), and these antibiotics have long been ...
Tumbarello M., Losito A. R., Giamarellou H.   +2 more
openaire   +3 more sources

Treatment of infections caused by carbapenemase-producing Enterobacteriaceae

Enfermedades Infecciosas y Microbiología Clínica, 2014
Treatment of infections caused by carbapenemase-producing Enterobacteriaceae (CPE) is currently one of the most important challenges of infectious diseases. The available information is based on in vitro studies, some animal model data and a few case studies and retrospective cohorts; appropriate data are lacking or are very scarce for some old ...
Jesús Rodríguez-Baño, José Antonio Martínez, José Miguel Cisneros, Carlota Gudiol   +3 more
openaire   +3 more sources

Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa [PDF]

Journal of Antimicrobial Chemotherapy, 1983
Sixteen patients with serious Gram-negative bacillary infections were treated with intravenous ceftazidime, 2 g every 8 h. The majority of patients had bacteraemia or pneumonitis or both. Ten patients were cured and six improved. Seven of ten patients infected with Pseudomonas aeruginosa were cured, and three improved.
Robert Press, Michael S. Simberkoff, Alan A. Pollock, Wafaa El-Sadr, Melanie J. Maslow, James J. Rahal, Alma S. Richmond, Amy Rosenberg, David Silverman   +8 more
openaire   +2 more sources

Risk of resistant infections with Enterobacteriaceae in hospitalized neonates

The Pediatric Infectious Disease Journal, 2002
To determine the risk factors associated with progression from colonization to infection with health care-associated antimicrobial-nonsusceptible Enterobacteriaceae (ANE) in critically ill neonates.During a 3-year period (1998 to 2000), surveillance rectal cultures were performed on neonates admitted to our Level III neonatal intensive care unit after ...
Nalini Singh, Bruce M. Sprague, Kantilal M. Patel, Joseph M. Campos, Nnenna Kalu, Billie L. Short, Marie-Michèle Leger   +6 more
openaire   +3 more sources

Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis

Infection control and hospital epidemiology, 2019
Background: Carbapenemase-producing Enterobacteriaceae (CPE) pose a significant global health threat. Objective: To conduct a systematic review of health outcomes and long-term sequelae attributable to CPE infection. Methods: We followed PRISMA reporting
Dalton R. Budhram, S. Mac, J. Bielecki, Samir N. Patel, B. Sander   +4 more
semanticscholar   +1 more source

Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae

Current Treatment Options in Infectious Diseases, 2014
Treatment of infections by carbapenem-resistant enterobacteriaceae (CRE) is challenging because of the limited choice of active antibiotics and the scarcity of good data supporting any treatment regimen. Currently, there are no randomized controlled trials on the treatment of CRE infections and all data have been obtained from case report and ...
Stephan Göttig, Axel Hamprecht
openaire   +2 more sources

ESBL-producing Enterobacteriaceae: controlling the spread of infection

British Journal of Nursing, 2007
Extended spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae were first reported in Europe in the 1980s and have since become a worldwide problem. This has resulted in increased morbidity, mortality and cost in treating the infections they cause (Paterson et al, 2001; Bisson et al, 2002). In the UK the prevalence of ESBL rose from 5.4% in 1997 to
openaire   +3 more sources